VC firm
Fund+
- Investor type
- VC
- Investing status
- Activeas of 2026-09-21Source (opens in a new tab)
- Headquarters
- Leuven, Belgium
- Founded
- 2015
- Check size
- The intended investment size per project will be between EUR 5 million and EUR 15 million.Source (opens in a new tab)
Claim, correct or request removal
Record updated 21 September 2026
About
Fund+ is an open-ended Fund for long term equity investment in innovative Life Sciences companies with a focus on Belgium.
Investment approach
- Thesis
- Fund+ wants to become a long term partner of companies, create value for its shareholders and generate and formally evaluate a tangible beneficial societal impact.Source (opens in a new tab)
- Takes board seats
- Yes
- Board policy
- Fund+ plays a constructive role as board member in our portfolio companies.
- Ownership target
- Fund+ aims to become a significant minority shareholder (more than 10%)
- Eligibility
- active in life sciences (primary focus on therapeutics, not excluding diagnostics and medical devices), with a strong patient-centric approach addressing unmet medical needs in an advanced development stage (first round and subsequent financing) with an experienced management team respecting highest ethical values presenting a solid business plan invest in Europe, with a focus on Belgium
- Traction requirement
- will have already a Proof of Concept (POC).
Locations
- Headquarters
- Leuven, Belgium
Loading relationship preview